Browse
Submit Data
Databases
API
Help

Dataset Information

5 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

A clinical trials based on SDC2/NDRG4 Gene Methylation Detection Kit (PCR-Fluorescence Probe Method) in vitro diagnostic reagent kit used to qualitative detection of human colorectal cancer genes based on their methylation status.

ABSTRACT: Interventions: Gold Standard:Colonoscopy, Pathological biopsy;Index test:Feces, SDC2/NDRG4 Gene Methylation Detection Kit Primary outcome(s): Sensitivity of the Kit in the diagnosis of colorectal cancer;Specificity of the Kit in the diagnosis of colorectal cancer Study Design: Diagnostic test for accuracy

DISEASE(S): Colorectal Cancer

PROVIDER: 113468 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

ACCESS DATA

Json Xml

Similar Datasets

Multi-center Clinical Trial of Methylation Detection Kit for SDC2 Gene (Real Time PCR) (Product Name: ColoSafe)

Project description:Interventions: Gold Standard:colonoscopy, Pathological examination;Index test:Methylation Detection Kit for SDC2 Gene (Real Time PCR)(Product Name: ColoSafe) Primary outcome(s): Sensitivity;Specificity;ACC;Kappa Study Design: Sequential

| 2687377 | ecrin-mdr-crc

Detection kit of the combination of methylated SDC2 and TFPI2 (fluorescence PCR method)

Project description:Interventions: Gold Standard:The double-blinded clinical trial was conducted to simultaneously assessing the kit with colonoscopy and/or pathological examinations for the detection of colorectal cancer. The overall coincidence rate of the kit in clinical practice was then calculated according to the results of statistical analysis.;Index test:Detection kit of the combination of methylated SDC2 and TFPI2 (fluorescence PCR method)(Product Name: iColocomf?) Primary outcome(s): Sensitivity;Specificity;Accuracy;Kappa Study Design: Sequential

| 2726190 | ecrin-mdr-crc

Therascreen KRAS RGQ PCR Kit

Project description:An interventional, prospective IVD device study for the testing of DNA extracted from tumor tissue biopsy samples from patients with Colorectal Cancer (CRC) who have previously tested positive for the KRAS G12C mutation for potential inclusion into the Amgen Phase III clinical trial (Protocol No 20190172) to demonstrate clinical performance of the therascreen KRAS RGQ PCR Kit

| 2720294 | ecrin-mdr-crc